Makale
Tam Makale
Uluslararası
2015
Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition.
Drug research
Cilt 65 · Sayı 5 · ss. 272 · 01.05.2015
Özet
Background: This study was designed to investigate the protective effects of bosentan an orally active non-peptide mixed ETA/ETB receptor antagonist, on liver injury in streptozotocin-induced diabetic rats.
Anahtar kelimeler
hypertension
oxidative stress
Diabetes
EXPRESSION
CELLS
cytokines
Rat
TYPE-1
liver
endothelin
GROWTH-FACTOR-BETA
MESENTERIC-ARTERIES
VASCULAR SUPEROXIDE
RENAL-DISEASE
INSULIN
BLOCKADE
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Demirci, E., Ferah Okkay, I., GUNDOGDU, C., Özkanlar, S., Kılıç Baygutalp, N., Bayır, Y., CALIK, M., & AYAZ, G. (2015). Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition. Drug research, 65(5), 272. https://doi.org/10.1055/s-0034-1377024
BibTeX
@article{demirci2015-18233,
author = {Demirci, Elif and Ferah Okkay, Irmak and GUNDOGDU, C and Özkanlar, Seçkin and Kılıç Baygutalp, Nurcan and Bayır, Yasin and CALIK, Muhammet and AYAZ, G},
title = {Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition.},
journal = {Drug research},
year = {2015},
volume = {65},
number = {5},
pages = {272},
issn = {2194-9379},
doi = {10.1055/s-0034-1377024},
url = {https://akademik.atauni.edu.tr/yayinlar/18233-endothelin-receptor-inhibition-with-bosentan-delays-onset-of-liver-injury-in}
}